‘Our strategy is working’: J&J Q3 net profit soars 21.6% 20-Oct-2022 By Kacey Culliney Personal care major Johnson & Johnson (J&J) has reported a rise in third quarter (Q3) sales and a surge in net profit, bolstered by strong growth in pharma and med tech but also solid results across its global consumer health business.